Evidence map›Paper›PMID 35314676›Full record

ReviewSignal transduction and targeted therapy2022

The secretion profile of mesenchymal stem cells and potential applications in treating human diseases.

Yuyi Han, Jianxin Yang, Jiankai Fang, Yipeng Zhou, Eleonora Candi, Jihong Wang, Dong Hua, Changshun Shao, Yufang Shi

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Signal transduction and targeted therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05784519 (Clinical Study of Mesenchymal Stem Cell Eye Drops for Treating Dry Eye Disease), which is not on this map. Cited by 437 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
437citing papers in PubMed, 5 pooled it
95.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05784519 early_phase1active not recruitingnot on this mapstarted 2023, after this paper: background citation

Clinical Study of Mesenchymal Stem Cell Eye Drops for Treating Dry Eye Disease

TypeinterventionalSponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolRan2023 to 2028Enrolled10ConditionsMesenchymal Stem Cell, Dry Eye SyndromesArmsMSCs eye drops
3 · Its place in the literature

Who cites it

437 citing papers in PubMed, 5 syntheses or guidelines pooled it, 655 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

377 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yuyi HanDepartment of Ophthalmology, The Affiliated Hospital of Jiangnan University, 214000, Wuxi, China.
Jianxin YangThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Key Laboratory of Stem Cells and Medical Biomaterials of Jiangsu Province, Medical College of Soochow University, 215000, Suzhou, China.
Jiankai FangThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Key Laboratory of Stem Cells and Medical Biomaterials of Jiangsu Province, Medical College of Soochow University, 215000, Suzhou, China.
Yipeng ZhouThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Key Laboratory of Stem Cells and Medical Biomaterials of Jiangsu Province, Medical College of Soochow University, 215000, Suzhou, China.
Eleonora CandiDepartment of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Roma, Italy.
Jihong WangDepartment of Ophthalmology, The Affiliated Hospital of Jiangnan University, 214000, Wuxi, China.
Dong HuaDepartment of Medical Oncology, The Affiliated Hospital of Jiangnan University, 214000, Wuxi, China.
Changshun ShaoThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Key Laboratory of Stem Cells and Medical Biomaterials of Jiangsu Province, Medical College of Soochow University, 215000, Suzhou, China. shaoc@suda.edu.cn.ORCID http://orcid.org/0000-0003-2618-9342
Yufang ShiThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Key Laboratory of Stem Cells and Medical Biomaterials of Jiangsu Province, Medical College of Soochow University, 215000, Suzhou, China. yfshi@suda.edu.cn.ORCID http://orcid.org/0000-0001-8964-319X
Soochow University · CNJiangnan University · CNUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stromal/stem cells (MSCs) possess multi-lineage differentiation and self-renewal potentials. MSCs-based therapies have been widely utilized for the treatment of diverse inflammatory diseases, due to the potent immunoregulatory functions of MSCs. An increasing body of evidence indicates that MSCs exert their therapeutic effects largely through their paracrine actions. Growth factors, cytokines, chemokines, extracellular matrix components, and metabolic products were all found to be functional molecules of MSCs in various therapeutic paradigms. These secretory factors contribute to immune modulation, tissue remodeling, and cellular homeostasis during regeneration. In this review, we summarize and discuss recent advances in our understanding of the secretory behavior of MSCs and the intracellular communication that accounts for their potential in treating human diseases.

Indexed as

Mesenchymal Stem CellsCell DifferentiationCytokinesHumansCytokines

Identifiers

PMID35314676
PMCPMC8935608
OpenAlexW4220659756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.